{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:48:53Z","timestamp":1787730533147,"version":"build-2784847793"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.suc.2024.05.003","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T01:16:36Z","timestamp":1721438196000},"page":"1007-1016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Indications for Radiation in Pancreatic Adenocarcinoma"],"prefix":"10.1016","volume":"104","author":[{"given":"Samuel","family":"Keltner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailey","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Kharofa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.suc.2024.05.003_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.suc.2024.05.003_bib3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jamcollsurg.2007.09.021","article-title":"Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms","volume":"206","author":"White","year":"2008","journal-title":"J\u00a0Am Coll Surg"},{"issue":"10073","key":"10.1016\/j.suc.2024.05.003_bib4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(16)32409-6","article-title":"Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial","volume":"389","author":"Neoptolemos","year":"2017","journal-title":"Lancet Lond Engl"},{"issue":"6","key":"10.1016\/j.suc.2024.05.003_bib5","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/SLA.0b013e31829b3ce4","article-title":"Preoperative gemcitabine-based chemoradiation therapy for resectable and borderline resectable pancreatic cancer","volume":"258","author":"Takahashi","year":"2013","journal-title":"Ann Surg"},{"issue":"16","key":"10.1016\/j.suc.2024.05.003_bib6","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1200\/JCO.19.02274","article-title":"Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the dutch randomized phase III PREOPANC trial","volume":"38","author":"Versteijne","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2024.05.003_bib7","doi-asserted-by":"crossref","first-page":"906484","DOI":"10.3389\/fonc.2022.906484","article-title":"Relationship of dose to vascular target volumes and local failure in pancreatic cancer patients undergoing neoadjuvant chemoradiation","volume":"12","author":"Nelson","year":"2022","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.suc.2024.05.003_bib8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/COC.0000000000000726","article-title":"Comparison of radiation treatment volumes for borderline resectable pancreatic cancer in contemporary clinical trials","volume":"43","author":"Bluemel","year":"2020","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"10.1016\/j.suc.2024.05.003_bib9","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jamcollsurg.2007.12.020","article-title":"Borderline resectable pancreatic cancer: the importance of this emerging stage of disease","volume":"206","author":"Katz","year":"2008","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.suc.2024.05.003_bib10","doi-asserted-by":"crossref","first-page":"S1323","DOI":"10.1016\/j.annonc.2023.10.084","article-title":"LBA83 Neoadjuvant chemotherapy with FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy for borderline resectable and resectable pancreatic cancer (PREOPANC-2): A multicenter randomized controlled trial","volume":"34","author":"Groot","year":"2023","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.suc.2024.05.003_bib11","doi-asserted-by":"crossref","first-page":"e161137","DOI":"10.1001\/jamasurg.2016.1137","article-title":"Preoperative modified FOLFIRINOX treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer: alliance for clinical trials in oncology trial A021101","volume":"151","author":"Katz","year":"2016","journal-title":"JAMA Surg"},{"issue":"2","key":"10.1016\/j.suc.2024.05.003_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S2468-1253(22)00348-X","article-title":"Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial","volume":"8","author":"Ghaneh","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.suc.2024.05.003_bib13","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jamaoncol.2022.2319","article-title":"Efficacy of preoperative mFOLFIRINOX vs mFOLFIRINOX Plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: the A021501 phase 2 randomized clinical trial","volume":"8","author":"Katz","year":"2022","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.suc.2024.05.003_bib14","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/annonc\/mdn281","volume":"19","author":"Chauffert","year":"2008","journal-title":"Ann Oncol"},{"issue":"31","key":"10.1016\/j.suc.2024.05.003_bib15","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1200\/JCO.2011.34.8904","article-title":"Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an eastern cooperative oncology group trial","volume":"29","author":"Loehrer","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.suc.2024.05.003_bib16","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ijrobp.2021.01.055","article-title":"Investigation of relation of radiation therapy quality with toxicity and survival in LAP07 phase 3 trial for locally advanced pancreatic carcinoma","volume":"110","author":"Giraud","year":"2021","journal-title":"Int J Radiat Oncol"},{"issue":"16_suppl","key":"10.1016\/j.suc.2024.05.003_bib17","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1200\/JCO.2022.40.16_suppl.4008","article-title":"Randomized phase III trial of induction chemotherapy followed by chemoradiotherapy or chemotherapy alone for nonresectable locally advanced pancreatic cancer: First results of the CONKO-007 trial","volume":"40","author":"Fietkau","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.suc.2024.05.003_bib18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaoncol.2021.0057","article-title":"Association of ablative radiation therapy with survival among patients with inoperable pancreatic cancer","volume":"7","author":"Reyngold","year":"2021","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.suc.2024.05.003_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1072-7515(99)00075-7","article-title":"Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985\u20131995, using the National Cancer Database11No competing interests declared","volume":"189","author":"Sener","year":"1999","journal-title":"J\u00a0Am Coll Surg"},{"issue":"4","key":"10.1016\/j.suc.2024.05.003_bib20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ijrobp.2014.07.024","article-title":"Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer","volume":"90","author":"Morganti","year":"2014","journal-title":"Int J Radiat Oncol"},{"issue":"8","key":"10.1016\/j.suc.2024.05.003_bib21","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archsurg.1985.01390320023003","article-title":"Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection","volume":"120","author":"Kaiser","year":"1985","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.suc.2024.05.003_bib22","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00000658-199912000-00006","article-title":"Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III Trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group","volume":"230","author":"Klinkenbijl","year":"1999","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.suc.2024.05.003_bib23","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/01.sla.0000229980.81505.44","article-title":"On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer","volume":"244","author":"Garofalo","year":"2006","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.suc.2024.05.003_bib24","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A\u00a0randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.suc.2024.05.003_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/COC.0000000000000633","article-title":"Results of the NRG oncology\/RTOG 0848 adjuvant chemotherapy question\u2014erlotinib+gemcitabine for resected cancer of the pancreatic head: a phase II randomized clinical trial","volume":"43","author":"Abrams","year":"2020","journal-title":"Am J Clin Oncol"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610924000835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610924000835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T08:11:34Z","timestamp":1725437494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610924000835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0039610924000835"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2024.05.003","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indications for Radiation in Pancreatic Adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2024.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}